90/015,145Flavanones For Use In Treating Visceral Hypersensitivity11,141,420Closed

Status

Reexamination Certificate Issued

Filed

Oct 27, 2022

Last Updated

Nov 13, 2023

Art Unit

3991

Requester

Unknown

Requester Law Firm

The Dobrusin Law Firm, P.C.

Requested By

Third Party

Patent OwnerInferred

Bioactor BV

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61KPharmaceutical Preparations

USPC

514Drug, Bio-Affecting And Body Treating Compositions

Reexam History (37 events)

Nov 14, 2023CCRDYApplication ready for PDX access by participating foreign offices
Nov 13, 2023REEXInput Issue Number and Issue Date for Reexamination
Oct 9, 2023RXPUBSReexam Forwarded to Office of Publications
Sep 27, 2023MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Sep 1, 2023RXC/SRCertificate of Service
Sep 1, 2023RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Sep 1, 2023RXAAF.Response to Final Filed (or Ready for Examiner Action)
Jul 3, 2023MRXFRRX - Mail Final Rejection
May 30, 2023RXC/SRCertificate of Service
May 30, 2023RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
May 30, 2023RXA...Response after Non-Final Action
Apr 27, 2023MRXG.RX - Mail Extension of Time Period for Response Granted
Apr 25, 2023RXRQ/TRequest for Extension of Time
Apr 25, 2023RXC/SRCertificate of Service
Feb 28, 2023MR.NFRX - Mail Reexam Non-Final Action
Feb 13, 2023DOCKCase Docketed to Examiner in GAU
Feb 3, 2023RXFWDXDate Forwarded to Examiner
Dec 20, 2022NRX.Notice of Reexam Published in Official Gazette
Nov 17, 2022MREXORX - Mail Ex Parte Request for Reexamination Granted
Nov 9, 2022RXLITSRReexam Litigation Search Conducted
Nov 1, 2022MRXNReexamination Formalities Notice Mailed
Nov 1, 2022MRXNReexamination Formalities Notice Mailed
Nov 1, 2022DOCKCase Docketed to Examiner in GAU
Oct 31, 2022RXTTLRPTTitle Report
Oct 31, 2022RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Oct 31, 2022FTFSFITF set to YES - revise initial setting
Oct 30, 2022RXNREQFDNotice of reexamination request filing date
Oct 30, 2022RXNREQAUNotice of assignment of reexamination request
Oct 27, 2022WIDSInformation Disclosure Statement (IDS) Filed
Oct 27, 2022RXOSUB.RReexamination requested by third party requester
Oct 27, 2022RXOSUBReceipt of Original Ex Parte Reexam Request
Oct 27, 2022RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Oct 27, 2022RXC/SRCertificate of Service
Oct 27, 2022RXC/SRCertificate of Service
Oct 27, 2022RXAF/DRReexam - Affidavit(s), Declaration(s) and/or Exhibit(s) Filed by Third Party Requester
Oct 27, 2022PDREQUSTRequest from applicant for the USPTO to retrieve the Priority Document
Oct 27, 2022BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
Oct 12, 2021
3.5-yr
Apr 12, 2025
Paid Apr 14, 2025
7.5-yr
Apr 12, 2029
11.5-yr
Apr 12, 2033
Expiry
Aug 21, 2039

Entity Status

Small Entity

Expires

Aug 21, 2039 (13.4 yr remaining)

Assignments

Apr 2018May 2018Jun 2018Jul 2018Aug 2018Sep 2018Oct 2018Nov 2018Dec 2018Jan 2019Feb 2019Mar 2019Apr 2019May 2019Jun 2019Jul 2019Aug 2019FiledBOUKE SALDENYALA STEVENSANTONIE JOHANNES VAN DER SAAGSAM POSSEMIERSBIOACTOR BV
AssignmentReel/Frame: 053624/0741Recorded: Aug 28, 2020

From

BOUKE SALDENInventor
Mar 13, 2018
YALA STEVENSInventor
Mar 21, 2018
ANTONIE JOHANNES VAN DER SAAGInventor
Apr 24, 2018

To

BIOACTOR BV

AssignmentReel/Frame: 053624/0823Recorded: Aug 28, 2020

From

SAM POSSEMIERSInventor
Aug 9, 2019

To

BIOACTOR BV